Host-response biomarkers for the diagnosis of bacterial respiratory tract infections
Publication date
2019-04-01
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
Appropriate antibiotic treatment for respiratory tract infections (RTIs) necessitates rapid and accurate diagnosis of microbial etiology, which remains challenging despite recent innovations. Several host response-based biomarkers due to infection have been suggested to allow discrimination of bacterial and non-bacterial microbial RTI etiology. This review provides an overview of clinical studies that investigated the diagnostic performance of host-response proteomic biomarkers to identify RTI microbial etiology. Procalcitonin and C-reactive protein have been studied most extensively; whereof procalcitonin has demonstrated the strongest diagnostic performance compared to other biomarkers. Proadrenomedullin, soluble triggering receptor expressed on myeloid cells-1, neopterin and pentraxin-3 need more studies to confirm their diagnostic value. For syndecan-4 and lipocalin-2 currently insufficient evidence exists. Common limitations in several of the studies were the relatively small scale setting, heterogeneous patient population and the absence of statistical power calculation.
Keywords
biomarkers, diagnosis, etiology, immunoresponse, respiratory infections
Citation
Saleh, M A A, van de Garde, E M W & van Hasselt, J G C 2019, 'Host-response biomarkers for the diagnosis of bacterial respiratory tract infections', Clinical Chemistry and Laboratory Medicine, vol. 57, no. 4, pp. 442-451. https://doi.org/10.1515/cclm-2018-0682